Note D - Notes Receivable
|12 Months Ended|
Dec. 31, 2018
|Notes to Financial Statements|
|Financing Receivables [Text Block]||
NOTE D — NOTES RECEIVABLE
June 2017,Milestone Scientific entered into an agreement for the sale of its
40%) interest in Milestone China (the “Milestone China Shares”) to an unaffiliated United States domiciled purchaser and a
10-year option agreement to repurchase the Milestone China Shares. The purchase price for the Milestone China Shares was
$125,000was paid in cash and
$1,275,000was paid by delivery of a non-interest bearing secured promissory note.
The note was payable in quarterly installments of
$125,000and was secured by the Milestone China Shares until full repayment. In addition, the purchaser was precluded from selling all or substantially all its assets prior to repayment of the note. The
10-year option agreement provides Milestone Scientific an option to repurchase the Milestone China Shares at
twoyears and at fair market value (as defined in such agreement) for the remainder of the
10-year term. The transaction was accounted for as a secured financing and Milestone Scientific continued to account for its relationship with Milestone China under the equity method of accounting. A note receivable was presented on the Company’s consolidated balance sheet along with a deferred gain from financing transaction of
$1,400,000.The carrying value of the
40%) percent investment in Milestone China at the transaction date was zero.
March 2, 2018,the promissory note was in default. In
April 2018,Milestone Scientific entered into a Release, Assignment and Termination Agreement (the “Termination Agreement”) with the issuer of the promissory note, pursuant to which, Milestone Scientific repaid the
$250,000payment made by the issuer and the issuer returned the Milestone China Shares to Milestone Scientific and cancelled the promissory note. Because of the Termination Agreement and related repayment made by Milestone Scientific, the Company derecognized the outstanding note receivable balance of
$1,150,000and the related deferred gain from financing transaction of
Nogain or loss was recognized on the transaction.
The entire disclosure for financing receivables. Examples of financing receivables include, but are not limited to, loans, trade accounts receivables, notes receivable, credit cards, and receivables relating to a lessor's right(s) to payment(s) from a lease other than an operating lease that is recognized as assets.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef